CureVac doses first subject in Phase I influenza vaccine trial
Set to be carried out in Panama, the trial is anticipated to enrol up to 240 healthy subjects.
Panama
Latest in
Panama
Turn Therapeutics enrols subjects in nasal Covid-19 treatment trial
Biotechnology company Turn Therapeutics has announced the enrolment of the first subjects in a clinical trial of its product, Hexagen,…